Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Early intervention of intravenous KB220IV--neuroadaptagen amino-acid therapy (NAAT) improves behavioral outcomes in a residential addiction treatment program: a pilot study.

Miller M, Chen AL, Stokes SD, Silverman S, Bowirrat A, Manka M, Manka D, Miller DK, Perrine K, Chen TJ, Bailey JA, Downs W, Waite RL, Madigan MA, Braverman ER, Damle U, Kerner M, Giordano J, Morse S, Oscar-Berman M, Barh D, Blum K.

J Psychoactive Drugs. 2012 Nov-Dec;44(5):398-409.

PMID:
23457891
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D₂ agonist therapy: part 2.

Blum K, Chen TJ, Morse S, Giordano J, Chen AL, Thompson J, Allen C, Smolen A, Lubar J, Stice E, Downs BW, Waite RL, Madigan MA, Kerner M, Fornari F, Braverman ER.

Postgrad Med. 2010 Nov;122(6):214-26. doi: 10.3810/pgm.2010.11.2237.

PMID:
21084796
[PubMed - indexed for MEDLINE]
3.

Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: a hypothesis.

Blum K, Gold MS.

Med Hypotheses. 2011 Apr;76(4):576-84. doi: 10.1016/j.mehy.2011.01.005.

PMID:
21306831
[PubMed - indexed for MEDLINE]
4.

Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).

Blum K, Chen TJ, Downs BW, Bowirrat A, Waite RL, Braverman ER, Madigan M, Oscar-Berman M, DiNubile N, Stice E, Giordano J, Morse S, Gold M.

Postgrad Med. 2009 Nov;121(6):176-96. doi: 10.3810/pgm.2009.11.2087. Review.

PMID:
19940429
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Acute intravenous synaptamine complex variant KB220™ "normalizes" neurological dysregulation in patients during protracted abstinence from alcohol and opiates as observed using quantitative electroencephalographic and genetic analysis for reward polymorphisms: part 1, pilot study with 2 case reports.

Miller DK, Bowirrat A, Manka M, Miller M, Stokes S, Manka D, Allen C, Gant C, Downs BW, Smolen A, Stevens E, Yeldandi S, Blum K.

Postgrad Med. 2010 Nov;122(6):188-213. doi: 10.3810/pgm.2010.11.2236. Review.

PMID:
21084795
[PubMed - indexed for MEDLINE]
6.

Neurogenetics and clinical evidence for the putative activation of the brain reward circuitry by a neuroadaptagen: proposing an addiction candidate gene panel map.

Chen TJ, Blum K, Chen AL, Bowirrat A, Downs WB, Madigan MA, Waite RL, Bailey JA, Kerner M, Yeldandi S, Majmundar N, Giordano J, Morse S, Miller D, Fornari F, Braverman ER.

J Psychoactive Drugs. 2011 Apr-Jun;43(2):108-27.

PMID:
21858957
[PubMed - indexed for MEDLINE]
7.

Costs and effectiveness of substance abuse treatments for homeless persons.

Schumacher JE, Mennemeyer ST, Milby JB, Wallace D, Nolan K.

J Ment Health Policy Econ. 2002 Mar;5(1):33-42.

PMID:
12529568
[PubMed - indexed for MEDLINE]
8.

Narcotic antagonists in drug dependence: pilot study showing enhancement of compliance with SYN-10, amino-acid precursors and enkephalinase inhibition therapy.

Chen TJ, Blum K, Payte JT, Schoolfield J, Hopper D, Stanford M, Braverman ER.

Med Hypotheses. 2004;63(3):538-48.

PMID:
15288384
[PubMed - indexed for MEDLINE]
9.

The Women's Recovery Group Study: a Stage I trial of women-focused group therapy for substance use disorders versus mixed-gender group drug counseling.

Greenfield SF, Trucco EM, McHugh RK, Lincoln M, Gallop RJ.

Drug Alcohol Depend. 2007 Sep 6;90(1):39-47. Epub 2007 Apr 18.

PMID:
17446014
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Treatment outcome of 600 chemically dependent patients treated in a multimodal inpatient program including aversion therapy and pentothal interviews.

Smith JW, Frawley PJ.

J Subst Abuse Treat. 1993 Jul-Aug;10(4):359-69.

PMID:
8105103
[PubMed - indexed for MEDLINE]
11.

Patient satisfaction, use of services, and one-year outcomes in publicly funded substance abuse treatment.

Carlson MJ, Gabriel RM.

Psychiatr Serv. 2001 Sep;52(9):1230-6.

PMID:
11533398
[PubMed - indexed for MEDLINE]
12.

Quantifying the clinical significance of cannabis withdrawal.

Allsop DJ, Copeland J, Norberg MM, Fu S, Molnar A, Lewis J, Budney AJ.

PLoS One. 2012;7(9):e44864. doi: 10.1371/journal.pone.0044864. Epub 2012 Sep 26.

PMID:
23049760
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

In-patient benzodiazepine withdrawal: comparison of fixed and symptom-triggered taper methods.

McGregor C, Machin A, White JM.

Drug Alcohol Rev. 2003 Jun;22(2):175-80.

PMID:
12850904
[PubMed - indexed for MEDLINE]
14.

Cognitive function in post-treatment Lyme disease: do additional antibiotics help?

Kaplan RF, Trevino RP, Johnson GM, Levy L, Dornbush R, Hu LT, Evans J, Weinstein A, Schmid CH, Klempner MS.

Neurology. 2003 Jun 24;60(12):1916-22.

PMID:
12821733
[PubMed - indexed for MEDLINE]
15.

Switching outpatients with bipolar or schizoaffective disorders and substance abuse from their current antipsychotic to aripiprazole.

Brown ES, Jeffress J, Liggin JD, Garza M, Beard L.

J Clin Psychiatry. 2005 Jun;66(6):756-60.

PMID:
15960570
[PubMed - indexed for MEDLINE]
16.

Prospective assessment of cannabis withdrawal in adolescents with cannabis dependence: a pilot study.

Milin R, Manion I, Dare G, Walker S.

J Am Acad Child Adolesc Psychiatry. 2008 Feb;47(2):174-8. doi: 10.1097/chi.0b013e31815cdd73.

PMID:
18176332
[PubMed - indexed for MEDLINE]
17.

Decision-making, reward-seeking behaviors and dopamine agonist therapy in restless legs syndrome.

Bayard S, Langenier MC, Dauvilliers Y.

Sleep. 2013 Oct 1;36(10):1501-7. doi: 10.5665/sleep.3044.

PMID:
24082309
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

[Alterations in the decision making processes linked to the ventromedial prefrontal cortex in drug-abusing patients].

Verdejo A, Aguilar de Arcos F, Pérez García M.

Rev Neurol. 2004 Apr 1-15;38(7):601-6. Spanish.

PMID:
15098178
[PubMed - indexed for MEDLINE]
Free Article
19.

Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action.

Jentsch JD, Roth RH, Taylor JR.

Prog Brain Res. 2000;126:433-53. Review.

PMID:
11105661
[PubMed - indexed for MEDLINE]
20.

Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.

Thobois S, Ardouin C, Lhommée E, Klinger H, Lagrange C, Xie J, Fraix V, Coelho Braga MC, Hassani R, Kistner A, Juphard A, Seigneuret E, Chabardes S, Mertens P, Polo G, Reilhac A, Costes N, LeBars D, Savasta M, Tremblay L, Quesada JL, Bosson JL, Benabid AL, Broussolle E, Pollak P, Krack P.

Brain. 2010 Apr;133(Pt 4):1111-27. doi: 10.1093/brain/awq032. Epub 2010 Mar 17.

PMID:
20237128
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk